References
- 1. Kásler M. Az onkológia alapjai. Medicina, Budapest, 2011;327-386.
- 2. Stewart B. W., Wild C. P. World Cancer Report. International Agency for Research on Cancer, Lyon 2014;422-431.
- 3. Gregoire V, Lefebve JL, Licitra A et al. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow up. Ann Oncol, 2010;21(suppl 5): v184-186.
- 4. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: head and neck cancers. Version 2.2013
- 5. Psyrri A, Rampias T, Vermorken JB The current and future impact of human papilloma virus on treatment of squamous cell carcinoma of the head and neck. Ann Oncol 2014; v25 2101-2115.
- 6. Huang H, Zhang B, Chen W et al. Human papillomavirus infection and prognostic predictors in patients with oropharyngeal squamous cell carcinoma, Asian Pacific Journal and Cancer Prevention, 2012;13:891-896.
- 7. Reich M, Leemans CR, Vermorken JB, et al. Best practices in the management of the psycho-oncologic aspects of head and neck cancer patients: recommendations from the European Head and Neck Cancer Society Make Sense Campaign. Ann Oncol, 2014;v25 2115-2124.
- 8. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer, 2013;v49 1374-1403.
- 9. Parkin DM, Boyd L, Walker LC. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. BJC, 2011;105:77-81.
- 10. Cancer in Wales 1995-2009 A comprehensive report, 2012.
- 11. Balagopal PG, George NA, Venugopal A. Tobacco related habits among first degree relatives of patients undergoing surgery for advanced head and neck malignancies in India, Asian Pacific Journal of Cancer Prevention, 2012;217-220.
- 12. Jerjes W, Upile T, Radli H at al. The effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: short communication, Head Neck Oncology, 2012; v12 4-6
- 13. Weinberg RA. The biology of cancer. Garland Science, New York, 2007; 725-796.
- 14. Chung CH, Lee JW, Slebos RJ et al. A 3’-UTR KRAS variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous carcinoma Ann Oncol, 2014;v25:2230-2236.